PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,679 | +214.6% | 52,647 | +358.2% | 0.00% | – |
| Q2 2023 | $51,705 | -67.8% | 11,490 | -59.2% | 0.00% | – |
| Q1 2023 | $160,660 | -83.1% | 28,186 | -82.1% | 0.00% | – |
| Q4 2022 | $953,257 | -13.9% | 157,824 | -5.8% | 0.00% | – |
| Q3 2022 | $1,107,000 | +58.8% | 167,478 | +25.5% | 0.00% | – |
| Q2 2022 | $697,000 | -25.3% | 133,495 | -1.3% | 0.00% | – |
| Q1 2022 | $933,000 | -4.5% | 135,237 | +72.3% | 0.00% | – |
| Q4 2021 | $977,000 | +340.1% | 78,482 | +1006.2% | 0.00% | – |
| Q3 2021 | $222,000 | +53.1% | 7,095 | +41.3% | 0.00% | – |
| Q2 2021 | $145,000 | -79.6% | 5,022 | -69.4% | 0.00% | – |
| Q1 2021 | $711,000 | +1931.4% | 16,421 | +3251.2% | 0.00% | – |
| Q4 2020 | $35,000 | – | 490 | +4800.0% | 0.00% | – |
| Q3 2020 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |